Skip to main content

BANK OF AMERICA CORP /DE/

Bank

Position in FLGT — Fulgent Genetics, Inc.

CIK 70858 CHARLOTTE, NC

Position in FLGT

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$1,917,269
-$2,099,464 QoQ
Shares Held
120,583
-21.1% QoQ
Ownership
0.425%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FLGT Over Time

Shares Held

Position Value (USD)

Derivatives in FLGT

reported options exposure · as of Jun 30, 2025
CallValue
$17,892
CallShares
900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

BANK OF AMERICA CORP /DE/ holds $6,863,803,811 across 34 Diagnostics & Research names. FLGT ranks #28 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FLGT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,917,269 120,583
2025-12-31 $4,016,733 152,902
2025-09-30 $3,531,271 156,251
2025-06-30 $1,841,384 92,625
2025-06-30 $17,892 900
2025-03-31 $2,434,900 144,077
2024-12-31 $1,478,725 80,061
2024-09-30 $2,983,201 137,285
2024-06-30 $2,563,527 130,659
2024-03-31 $3,636,702 167,590
2023-12-31 $2,998,340 103,713
2023-09-30 $1,625,870 60,803
2023-06-30 $3,645,452 98,446
2023-03-31 $4,098,372 131,274
2022-12-31 $1,283,933 43,114
2022-09-30 $836,733 21,950
2022-06-30 $1,178,119 21,605
2022-03-31 $2,811,257 45,045
2021-12-31 $2,743,892 27,278
2021-09-30 $2,657,570 29,545
2021-06-30 $2,738,123 29,688
2021-03-31 $4,355,725 45,081
2020-12-31 $787,125 15,108
2020-09-30 $450,169 11,243
2020-06-30 $181,632 11,352
2020-03-31 $85,014 7,901